Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study

Prognostic Significance of Log(CA125)/PCI for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study

Can He,1 Niresh Thapa,1,2 Yang Wang,1 Ziye Song,1 Jing Yang,1 Mengfei Xu,1 Na Zuo,1 Hongbing Cai1 1Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Wuhan 430071, Hubei, People&rsqu...

Full description

Bibliographic Details
Main Authors:	He C, Thapa N, Wang Y, Song Z, Yang J, Xu M, Zuo N, Cai H
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-03-01
Series:	Cancer Management and Research
Subjects:	epithelial ovarian cancer peritoneal carcinomatosis index resectability cancer antigen 125 primary debulking surgery
Online Access:	https://www.dovepress.com/prognostic-significance-of-logca125pci-for-the-resectability-of-epithe-peer-reviewed-article-CMAR

Similar Items

Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
by: Lu Qin, et al.
Published: (2018-06-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-12-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-11-01)

Parcelar gastric resection in association with bowel resections as part of debulking surgery for advanced stage ovarian cancer – a case report
by: Nicolae Bacalbasa, et al.
Published: (2021-06-01)

Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
by: Tung Tung Tsoi, et al.
Published: (2020-05-01)

Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer
by: Merlo Sebastjan, et al.
Published: (2021-08-01)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
by: Juan Fernando Sánchez Vega, et al.
Published: (2018-05-01)

CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)

Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023-11-01)

The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis
by: Phelopatir Anthony, MD, MS, et al.
Published: (2024-06-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Cisplatin, cyclophosphamide versus taxol, carboplatin in epithelial ovarian carcinoma: a clinical trial
by: Modarres M, et al.
Published: (2007-05-01)

Tuberculous peritonitis with elevated serum CA125 levels mimicking peritoneal cancer
by: A. Taniwaki, et al.
Published: (2020-12-01)

Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
by: Ke Huang, et al.
Published: (2023-02-01)

Critical Analysis of Advanced High-Grade Serous Epithelial Ovarian Cancer in Women: An Experience of 100 Cases from a Regional Cancer Center in Northeast India
by: Debabrata Barmon, et al.
Published: (2023-10-01)

Isolated carcinomatosis of the abdominal cavity in women: the features of immunophenotypes and morphometric parameters.
by: О. V. Poslavska, et al.
Published: (2018-11-01)

The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
by: Xin Luo, et al.
Published: (2023-09-01)

Difficult Case of Peritoneal Serous Papillary Carcinoma with an Unusual Complication
by: Fu-Chieh Hsu, et al.
Published: (2024-01-01)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
by: Xiayu Jin, et al.
Published: (2022-12-01)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
by: Emre Günakan, et al.
Published: (2020-01-01)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
by: Jie-Ping Chen, et al.
Published: (2019-07-01)

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020
by: Yi Q, et al.
Published: (2021-01-01)

The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma
by: Joseph Menczer, et al.
Published: (2015-01-01)

Peritoneal tuberculosis: radiographic diagnosis
by: Carolina Ospina-Moreno, et al.
Published: (2014-12-01)

Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
by: Guo Junhong, et al.
Published: (2017-05-01)

Microscopic Peritoneal Residual Disease after Complete Macroscopic Cytoreductive Surgery for Advanced High Grade Serous Ovarian Cancer
by: Henri Azaïs, et al.
Published: (2020-12-01)

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
by: Akira Ueda, et al.
Published: (2024-02-01)

Correlation of Molecular Tumor Markers CA125, HE4, and CEA with the Development and Progression of Epithelial Ovarian Cancer
by: Qiuhua Wan, et al.
Published: (2021-06-01)

Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass
by: Alireza Rezaee, et al.
Published: (2019-07-01)

Value of CA-125 in diagnosis and assessment of severity of active pulmonary tuberculosis
by: Osama Ibrahim Mohammad, et al.
Published: (2016-01-01)

Sclerosing peritonitis associated with luteinized thecoma and elevated serum CA 125 levels: case report
by: Sabas Carlos Vieira, et al.

Assessment of carcinoembryonic antigen as a prognostic marker in ovarian malignancies treated in a rural hospital of West Bengal
by: Phalguni Chakrabarti, et al.
Published: (2022-05-01)

CA125, CEA, CA19-9, and Heteroploid Cells in Ascites Fluid May Help Diagnose Peritoneal Carcinomatosis in Patients with Gastrointestinal and Ovarian Malignancies
by: Deng L, et al.
Published: (2020-10-01)

A Rare Case of Peritoneal Sarcoidosis in a 36-Year-Old Construction Worker
by: Saman Chubineh, et al.
Published: (2008-11-01)

Over Kanserli Hastalarda CA-125 ve Seruloplazmin Düzeyleri
by: Mangala HEGDE, et al.
Published: (2015-09-01)

Correlation of Preoperative HE-4 and CA125 with Ovarian Cancer Staging in Ahvaz Imam Khomeni Hospital
by: Fatemeh Cheraghi, et al.
Published: (2020-01-01)

The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
by: Katrin Kleinmanns, et al.
Published: (2020-11-01)

Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
by: Sue Cheeseman, et al.
Published: (2023-01-01)

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
by: Eleonora Ghisoni, et al.
Published: (2018-05-01)

Simultaneous Surgical Approach with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Concurrent Peritoneal and Liver Metastases of Colon Cancer Origin
by: Rafael Morales-Soriano, et al.
Published: (2023-06-01)